-
ABU Dhabi launches Hope Consortium for global vaccine distribution
expresspharma
November 27, 2020
Five million vaccines have been transported in November on behalf of the Department of Health – Abu Dhabi.
-
When and which COVID-19 vaccines are likely to be available in Asia
expresspharma
November 27, 2020
Many Asian countries do not expect to receive big amounts initially, and below are estimated distribution timelines, supply deals announced so far and clinical trials under way in the region.
-
PM to visit Serum Institute of India in Pune on Nov 28
expresspharma
November 27, 2020
The CDSCO has granted permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms.
-
EU drugs watchdog expects first application for COVID-19 vaccine in days
expresspharma
November 27, 2020
Europe’s drugs watchdog said on Thursday it expects to receive the first application for conditional marketing approval for a COVID-19 vaccine “in the coming days”, the latest step towards making a shot available outside the United States.
-
CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine
expresspharma
November 27, 2020
Instead of adding the trial to an ongoing US process, AstraZeneca might launch a fresh study to evaluate a lower dosage of its vaccine that performed better than a full dosage.
-
City of Hope begins phase 1 clinical trial of Covid-19 vaccine candidate
pharmaceutical-business-review
November 26, 2020
City of Hope, the US-based independent biomedical research and treatment centre, has commenced phase 1 clinical trial to evaluate its first SARS-CoV-2 investigational vaccine.
-
Sputnik V COVID-19 vaccine over 90 percent effective, interim data shows
europeanpharmaceuticalreview
November 26, 2020
Phase III trial interim data has shown that Russia’s COVID-19 vaccine candidate, Sputnik V, is 91.4 percent effective.
-
AstraZeneca COVID-19 Vaccine Meets Primary Efficacy Endpoint
americanpharmaceuticalreview
November 25, 2020
Positive high-level results from an interim analysis of clinical trials of AstraZeneca’s COVID-19 vaccine, AZD1222, in the UK and Brazil showed the vaccine was highly effective in preventing Coronavirus.
-
EU reaches deal to procure 160 million doses of Moderna’s Covid-19 vaccine candidate
pharmaceutical-technology
November 25, 2020
The European Union has reached a deal to procure up to 160 million doses of US biotech Moderna’s experimental Covid-19 vaccine candidate.
-
EU reaches supply deal with Moderna for 160 mn doses of COVID-19 vaccine
expresspharma
November 25, 2020
The European Commission (EU) has reached a deal with US biotech firm Moderna for the supply of its COVID-19 vaccine candidate, an EU official told Reuters.